A veterinary practice that sends every chemistry panel to a reference lab pays for convenience and gives up speed. A practice that runs every panel in house pays for reagents, quality control, maintenance, and staff time — and risks losing revenue on tests that never get billed. The right answer for most general practices is not one or the other. It is a deliberate split: in-house for stat cases and pre-anesthetic screens, reference lab for comprehensive panels and anything the in-house analyzer's menu cannot cover.

This article walks through the financial and operational comparison. It covers the dominant equipment and pricing models (reagent rental agreement, lease, purchase), the cost-per-test math, the missed-charge problem that erodes in-house margins, the quality-control burden, the turnaround-time tradeoff, and the break-even volume where in-house chemistry generates more contribution margin than sending out.

The market landscape

The global veterinary chemistry analyzer market was valued at $1.8 billion in 2024 and is projected to grow at 9.4% CAGR through 2034, per GM Insights. IDEXX Laboratories holds the dominant installed base: 75,100 Catalyst chemistry analyzers worldwide as of Q1 2025, growing 7% year over year. Antech Diagnostics (part of Mars Veterinary Health) operates the competing reference-lab network. Most general practices in the United States interact with one or both.

The two modalities are not purely competitive. IDEXX's 2025 Investor Day data shows that 57% of IDEXX reference-lab customers also use an in-house IDEXX chemistry platform — a dual-modality model that is now the norm rather than the exception. The question for a practice is not "which one?" but "what split, and what triggers each path?"

Equipment and pricing models

In-house analyzers: the major platforms

The three ownership models

Reagent rental agreement (most common for IDEXX and Zoetis). The manufacturer places the analyzer in the practice at no upfront cost. The practice commits to purchasing a minimum volume of reagent consumables per month (often 50–100 tests). There is no capital expenditure and no maintenance fee during the agreement. The tradeoff: the practice is locked into a single reagent supplier at manufacturer-set pricing, and there may be penalties for falling below the monthly minimum. IDEXX's IDEXX 360 program offers "no capital investment or lease required" and "no maintenance fees for analyzers" with a "worry-free first-year commitment."

Lease. The practice leases the equipment over 3–5 years, paying a monthly equipment fee plus reagent costs. The practice owns the analyzer at the end of the lease term. This model is less common now that reagent-rental agreements dominate, but it may appear with refurbished or third-party equipment.

Purchase. The practice buys the analyzer outright. Benchtop chemistry analyzers for veterinary use range from approximately $3,000–$10,000 for cartridge-based systems (e.g., VetScan VS2) to $25,000–$50,000 for higher-throughput wet-chemistry units, per Lighthouse Lab Services' lab cost breakdown. The practice then pays only for reagents and maintenance. This model has the lowest per-test cost at high volumes but requires capital and carries maintenance risk.

Cost-per-test comparison

Published list prices vary by region, contract tier, and panel selection. The numbers below represent typical ranges reported by equipment resellers and practice consultants in 2025–2026. Actual pricing depends on the practice's contract with the manufacturer or distributor.

In-house chemistry panel (e.g., 15-analyte general chemistry panel)

Axonia Medical's published pricing for the IDEXX Catalyst One CLIP CHEM 15 panel shows a reagent cost of approximately $32 per panel. A typical practice charge to the client is $70–$100 per panel, producing a gross margin of $26–$70 per test before the overhead allocation above.

Reference lab chemistry panel

Antech's 2026 pricing updates reference a tiered panel structure (CoreChem, VetScreen, SuperChem) where the cost depends on the panel depth the veterinarian selects. IDEXX's reference lab pricing follows a similar tiered model.

The comparison

At first glance, the per-test cost is similar. The margin difference comes from two places:

1. Charge capture. A practice running a panel in house and charging the client $80–$100 generates a higher absolute margin than a reference-lab panel where the practice charges $80–$100 and pays the lab fee. But only if the in-house test is actually billed — which, as discussed below, is not always the case.
2. Turnaround time value. A stat chemistry result in 8–12 minutes enables same-visit treatment decisions. A reference-lab result returned the next day may require a second appointment, a phone callback, or a missed follow-up. The revenue impact of that workflow difference is harder to quantify but real.

The missed-charge problem

This is the underappreciated cost of in-house diagnostics. The American Animal Hospital Association reports that 17% of laboratory tests performed in veterinary practices go unbilled. Other industry sources estimate that the average practice misses 5–10% of all charges. KSM (Katz, Sapper & Miller) calculates that a practice grossing $2 million per year could be losing $100,000–$200,000 in unbilled services — and lab tests are a leading category.

The missed-charge rate is higher for in-house tests than for reference-lab tests because:

• Reference labs send an invoice. The invoice triggers the billing process. There is an external document reminding the practice to bill.
• In-house tests generate no external document. The analyzer prints a result, the veterinarian reviews it, and no one enters a charge. This is especially common in busy practices where the technician runs the panel and the doctor reviews the result during a workup but the front desk is never notified.

Fix: Configure the PIMS to auto-add the chemistry panel charge when the analyzer result is imported. Both IDEXX VetLab Station and Zoetis VetScan can push results into most major PIMS platforms. Set the integration so that importing a result auto-populates the invoice line item. If the practice does not have integration, create a billing checklist at the analyzer station: run test → print result → write patient name and charge on the daily billing log → initial.

Quality-control burden

In-house analyzers require ongoing quality control. This is a real cost in time, materials, and cognitive load.

What QC requires

• Daily or per-run QC. Most manufacturers recommend running at least two levels of QC material (normal and abnormal) at the start of each day or before the first patient sample. IDEXX's Catalyst analyzers use an internal "intelligent QC" (iQC) system that automates some checks, but external QC materials are still recommended on a scheduled basis.
• Calibration. Dry-slide and cartridge systems are typically factory-calibrated, but calibration verification may be required after a reagent lot change, a service event, or at a manufacturer-specified interval.
• Record keeping. Every QC result must be recorded. A QC failure means the analyzer is pulled from use until the issue is resolved. QC records are reviewed during AAHA accreditation evaluations.

Reference lab advantage

Reference labs absorb QC costs. Antech and IDEXX reference labs run panels on high-throughput analyzers that are calibrated and QC-tested multiple times per day by trained laboratory technologists. The practice pays none of the QC labor or material cost. This is a meaningful advantage for low-volume practices that would run QC material more often than they run patient samples.

The turnaround-time decision

The clinical value of immediate results is unambiguous for emergencies and pre-anesthetic screens. For wellness screening, the value depends on whether the practice's workflow uses the chemistry result as a client-education touchpoint during the visit or as a follow-up communication.

Break-even analysis: when does in-house win?

The break-even point depends on volume, charge capture, and the practice's contract terms. Here is a simplified model:

Assumptions:

• In-house reagent cost: $32 per panel
• Reference lab fee: $25 per panel
• Client charge: $85 per panel (in-house or sent out)
• Staff time cost: $3 per in-house test; $1.50 per sent-out test
• Missed-charge rate: 10% in-house (conservative, given AAHA's 17% figure); 3% sent out

Under these assumptions, the reference lab generates higher per-test margin because the missed-charge penalty on in-house tests outweighs the reagent-cost advantage. But if the practice fixes its charge-capture process (auto-billing on result import), the math flips:

Even at 100% capture, the reference lab still wins on per-test margin in this scenario because the lab fee ($25) is lower than the reagent cost ($32). The in-house advantage emerges when:

1. The practice negotiates a lower reagent cost (high-volume contracts can bring reagent cost below reference-lab panel pricing).
2. The practice values the workflow benefit of same-visit results — fewer callbacks, fewer missed follow-ups, higher client satisfaction, higher compliance with recommended testing.
3. The practice runs enough stat panels that the reference lab's next-day TAT is a clinical and workflow liability.

A practical guideline used by practice consultants: if the practice runs more than 15–20 chemistry panels per week, and charge capture is reliable, in-house chemistry typically produces higher total contribution margin after accounting for the workflow and follow-up revenue. Below that volume, the reference lab's lower per-test cost and zero QC burden make it the better primary channel, with an in-house analyzer reserved for stat use only.

The dual-modality model

The 57% overlap rate reported in IDEXX's Investor Day data reflects the dominant practice pattern: use both.

• In-house: Pre-anesthetic panels, emergency/stat chemistries, rapid recheck monitoring (e.g., renal values during hospitalization), and any clinical scenario where a same-visit result changes the treatment plan.
• Reference lab: Comprehensive wellness panels that include analytes outside the in-house menu, endocrine testing, bile acids, drug levels, histopathology, and any test where reference-lab methodology offers superior accuracy or a broader analyte list.

This split requires the practice to define clear rules — written into the medical protocols — for when each channel is used. Without rules, the default becomes whatever is most convenient for the person drawing the blood, which is not always the most profitable or clinically appropriate path.

Contract language to review

Before signing a reagent-rental agreement or lease:

1. Minimum monthly volume. What is the penalty for falling below the minimum? Some contracts charge a fee; others simply adjust pricing to a higher per-test tier.
2. Exclusivity. Does the contract prohibit the practice from using a competing analyzer or reference lab? Most reagent-rental agreements do not — the practice commits to buying reagents, not to sending all testing in-house — but the language should be confirmed.
3. Equipment return. What happens at the end of the agreement? Can the practice return the analyzer without penalty? Is there a buyout option?
4. Maintenance and repair. Is maintenance included? What is the guaranteed service response time? IDEXX's reagent-rental model typically includes maintenance; a purchased analyzer does not.
5. Reagent price escalation. Is there an annual price increase cap? Review the contract for language about inflationary adjustments tied to CPI or a fixed percentage.

Sources

• GM Insights. Veterinary Chemistry Analyzer Market Size Report, 2025–2034. https://www.gminsights.com/industry-analysis/veterinary-chemistry-analyzer-market
• IDEXX Laboratories. 10-K Annual Report, FY 2025. U.S. SEC. https://ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000038/idxx-20251231.htm
• IDEXX Laboratories. Investor Day 2025 Presentation. https://www.idexx.com/files/2025-08-14-idexx-investor-day.pdf
• IDEXX. In-House Veterinary Analyzers — Catalyst One Chemistry Analyzer. https://www.idexx.com/en/veterinary/analyzers
• Antech Diagnostics. 2026 Test Pricing. https://www.antechdiagnostics.com/pricing
• KSM (Katz, Sapper & Miller). How Veterinary Practices Can Capture Missed Charges. https://www.ksmcpa.com/insights/how-veterinary-practices-can-capture-missed-charges
• ezyVet. The Foolproof Way to Reduce Missed Charges in Your Vet Practice. https://www.ezyvet.com/blog/the-foolproof-way-to-reduce-missed-charges-in-your-vet-practice
• New Vet Equipment. Choosing an In-House Veterinary Chemistry Analyzer. https://newvetequipment.com/blog/choosing-an-in-house-chemistry-analyzer
• Lighthouse Lab Services. How Much Does It Cost to Build a Clinical Laboratory? https://www.lighthouselabservices.com/how-much-does-it-cost-to-build-a-clinical-laboratory
• Excedr. How Much Does a Clinical Chemistry Analyzer Cost? https://www.excedr.com/blog/clinical-chemistry-analyzer-cost
• Axonia Medical. IDEXX Catalyst One Veterinary Chemistry Analyzer. https://axoniamedical.com/chemistry-analyzer/82-idexx-catalyst-one.html
• GM Insights. Veterinary Reference Laboratory Market Size Report, 2026–2035. https://www.gminsights.com/industry-analysis/veterinary-reference-laboratory-market
• AAHA Guidelines Hub. American Animal Hospital Association. https://www.aaha.org/for-veterinary-professionals/aaha-guidelines
• Merck Veterinary Manual. Clinical Pathology and Procedures — Laboratory Diagnostics. https://www.merckvetmanual.com/clinical-pathology-and-procedures